Quest Diagnostics Q3 Results, EQT to Take Qiagen Private, Abbott Nutrition Spinoff — Oct 22, 2026

The Diagnostics & Lab Testing Business Brief · Oct 22, 2026 · 7m

The Diagnostics & Lab Testing Business Brief — Thursday, October 22, 2026

The business behind the tests. Today's developments shaping the diagnostics industry.

Quest Diagnostics Q3 2026 results: revenue of $3.10 billion, up 10.0%, adjusted EPS of $3.00, and full-year revenue and EPS guidance raised; the company also finalized an outreach lab asset acquisition agreement and extended its AD-Detect menu with the FDA-cleared Roche Elecsys pTau217 blood test. Source: PR Newswire — Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

EQT…